PIRA(progression independent of relapse activity)
搜索文档
Immunic (NasdaqGS:IMUX) 2026 R&D Day Transcript
2026-09-10 00:02
Immunic (NasdaqGS:IMUX) 2026 R&D Day September 09, 2026 11:00 AM ET Company ParticipantsJessica Breu - VP of Investor Relations and CommunicationsErik Lundgren - CEOAmit Bar-Or - Melissa and Paul Anderson President's Distinguished Professor of NeurologyHella Kohlhof - Co-Founder and Chief Scientific OfficerMike Panzara - CMOStephen Krieger - Professor of NeurologyJason Tardio - President and COOConference Call ParticipantsMyles Minter - AnalystYatin Suneja - AnalystMarc Goodman - AnalystJessica Breuas devel ...